Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
4.710
-0.200 (-4.07%)
May 19, 2026, 10:41 AM EDT - Market open
Savara Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
70
Market Cap
1.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 257.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 400.00K | 346.00K | 640.74% |
| Dec 31, 2015 | 54.00K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | 300.00K | -200.00K | -40.00% |
| Dec 31, 2008 | 500.00K | - | - |
| Dec 31, 2007 | 500.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortrea Holdings | 2.71B |
| AbCellera Biologics | 79.21M |
| Septerna | 72.26M |
| Wave Life Sciences | 71.80M |
| Maze Therapeutics | 20.00M |
SVRA News
- 19 hours ago - Savara Announces New Exercise Capacity Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Business Wire
- 6 days ago - Savara reports Q1 EPS (15c), consensus (14c) - TheFly
- 6 days ago - Savara Reports First Quarter Financial Results and Provides Business Update - Business Wire
- 6 days ago - Savara Slides: Corporate presentation - Filings
- 7 days ago - Savara Quarterly report: Q1 2026 - Filings
- 7 days ago - Savara Earnings release: Q1 2026 - Filings
- 7 days ago - Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference - Business Wire
- 25 days ago - Savara Proxy statement: Proxy filing - Filings